| Outcome Measures: |
Primary: Hospitalization due to SARS-CoV-2 infection, Number of patients hospitalized due to COVID-19, 3 months | Secondary: SARS-CoV-2 infection, Number of patients with verified SARS-CoV-2 infection, 3 months|SARS-CoV-2 viral load, SARS-CoV-2 viral count as defined by real-time RNA polymerase chain reaction, 3 months|All-cause mortality, Number of deaths within the study period, 3 months|Requirement of mechanical ventilation, Number of patients requiring mechanical ventilation due to SARS-CoV-2 infection within the study period, 3 months|Admission to intensive care, Number of patients admitted to intensive care due to SARS-CoV-2 infection within the study period, 3 months | Other: Duration of hospitalization, Duration in days of hospitalization due to SARS-CoV-2 infection, 3 months|Duration of mechanical ventilation, Duration in day of mechanical ventilation due to SARS-CoV-2 infection, 3 months|Duration of admission to intensive care, Duration in days of admission to intensive care due to SARS-CoV-2 infection, 3 months|Bone marrow suppression, Number of patients with leucopeni \< 3000/μL within the study period, 3 months|Hepatic dysfunction, Number of patients with hepatic dysfunction as defined by an alanine transaminaease \> 250U/I within the study period, 3 months|Cardiac injury, Number of patients with evidence of cardiac injury (creatinine kinase-myocardial band \> 5μg/L) within the study period, 3 months|Sudden cardiac death, Number of patients with sudden cardiac death within the study period, 3 months|QTc prolongation, Number of patients with QTc prolongation (Bazett's formula; \>\> 450 ms in males and 460 ms in females), 3 months|Positiv SARS-CoV-2 antibody, Number of patients with positive SARS-CoV-2 antibody at 3 months, 3 months
|
| Locations: |
Rigshospitalet, Copenhagen, 2100, Denmark|Herlev Hospital, Herlev, 2730, Denmark|North Zealand Hospital, Hillerød, 3400, Denmark
|
